Gerresheimer AG (ETR: GXI)
Germany
· Delayed Price · Currency is EUR
69.25
-0.90 (-1.28%)
Nov 21, 2024, 2:18 PM CET
Gerresheimer AG Revenue
Gerresheimer AG had revenue of 498.51M EUR in the quarter ending August 31, 2024, with 2.17% growth. This brings the company's revenue in the last twelve months to 2.01B, up 1.93% year-over-year. In the fiscal year ending November 30, 2023, Gerresheimer AG had annual revenue of 1.99B with 9.54% growth.
Revenue (ttm)
2.01B
Revenue Growth
+1.93%
P/S Ratio
1.21
Revenue / Employee
167.52K
Employees
11,660
Market Cap
2.43B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Nov 30, 2023 | 1.99B | 173.39M | 9.54% |
Nov 30, 2022 | 1.82B | 319.09M | 21.30% |
Nov 30, 2021 | 1.50B | 79.22M | 5.58% |
Nov 30, 2020 | 1.42B | 26.53M | 1.91% |
Nov 30, 2019 | 1.39B | 24.53M | 1.79% |
Nov 30, 2018 | Pro | Pro | Pro |
Nov 30, 2017 | Pro | Pro | Pro |
Nov 30, 2016 | Pro | Pro | Pro |
Nov 30, 2015 | Pro | Pro | Pro |
Nov 30, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionGerresheimer AG News
- 8 days ago - EQS-DD: Gerresheimer AG: Dietmar Siemssen, buy - Wallstreet:Online
- 5 weeks ago - EQS-News: Solar power for Gerresheimer site in Momignies, Belgium - Wallstreet:Online
- 6 weeks ago - Gerresheimer AG (GRRMY) Q3 2024 Earnings Call Highlights: Navigating Growth Amid Challenges - GuruFocus
- 6 weeks ago - Gerresheimer shares jump as activist investor buys over 5% stake - Reuters
- 7 weeks ago - Gerresheimer AG Slashes Growth Forecast for 2024 and 2025 - Wallstreet:Online
- 7 weeks ago - EQS-Adhoc: Gerresheimer AG: Adjustment of growth guidance for 2024 and 2025 - Wallstreet:Online
- 2 months ago - Stevanato Group, Gerresheimer and SCHOTT Pharma, Announce Strategic Industry “Alliance for RTU” - Wallstreet:Online
- 2 months ago - EQS-News: SCHOTT Pharma, Gerresheimer, and Stevanato Group announce strategic industry “Alliance for RTU” - Wallstreet:Online